The new coronary vasodilators: calcium blockers

L. D. Hillis

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Considerable clinical promise is being shown by a group of investigational drugs that inhibit the movement of calcium into cells, thereby reducing both coronary and systemic vascular resistance and depressing myocardial contractility. In studies conducted here and abroad, calcium blockers appear to reduce the frequency of both typical and variant angina attacks and limit the extent and severity of myocardial injury in acute infarctions. Some of these agents also combat supraventricular tachyarrhythmias and reduce blood pressure in patients with systemic arterial hypertension.

Original languageEnglish (US)
Pages (from-to)583-590
Number of pages8
JournalJournal of Cardiovascular Medicine
Issue number6
StatePublished - Jan 1 1980

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'The new coronary vasodilators: calcium blockers'. Together they form a unique fingerprint.

Cite this